These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk. Aggarwal A; Kabbani SS; Rimmer JM; Gennari FJ; Taatjes DJ; Sobel BE; Schneider DJ Am J Kidney Dis; 2002 Aug; 40(2):315-22. PubMed ID: 12148104 [TBL] [Abstract][Full Text] [Related]
5. Hemostatic changes in patients with end stage renal disease undergoing hemodialysis. Rios DR; Carvalho Md; Lwaleed BA; Simões e Silva AC; Borges KB; Dusse LM Clin Chim Acta; 2010 Feb; 411(3-4):135-9. PubMed ID: 19945449 [TBL] [Abstract][Full Text] [Related]
6. Platelet function in patients on maintenance hemodialysis: depressed or enhanced? Remuzzi G; Benigni A; Dodesini P; Schieppati A; Gotti E; Livio M; Mecca G; Donati B; de Gaetano G Clin Nephrol; 1982 Feb; 17(2):60-3. PubMed ID: 7067167 [TBL] [Abstract][Full Text] [Related]
7. [Disorders of haemostasis in patients undergoing maintenance haemodialysis, with special reference to recurrent arteriovenous fistula thrombosis. Effects of dipyridamole (author's transl)]. Jacques C; Drueke T; Nedellec J; Kremp O; Gazengel C Pathol Biol (Paris); 1976 Dec; 24 Suppl():27-32. PubMed ID: 827731 [TBL] [Abstract][Full Text] [Related]
8. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production. Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415 [TBL] [Abstract][Full Text] [Related]
9. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation. Ballow A; Gader AM; Huraib S; Al-Husaini K; Mutwalli A; Al-Wakeel J Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892 [TBL] [Abstract][Full Text] [Related]
10. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients. Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485 [TBL] [Abstract][Full Text] [Related]
11. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia. Elshamaa MF; Elghoroury EA; Helmy A Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197 [TBL] [Abstract][Full Text] [Related]
12. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure]. Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647 [TBL] [Abstract][Full Text] [Related]
13. The influence of the haemodialysis procedure on platelets, coagulation and fibrinolysis. Sabovic M; Salobir B; Preloznik Zupan I; Bratina P; Bojec V; Buturovic Ponikvar J Pathophysiol Haemost Thromb; 2005; 34(6):274-8. PubMed ID: 16772739 [TBL] [Abstract][Full Text] [Related]
14. Deep vein thrombosis in end-stage renal disease. Ifudu O; Delaney VB; Barth RH; Friedman EA ASAIO J; 1994; 40(1):103-5. PubMed ID: 8186484 [TBL] [Abstract][Full Text] [Related]
15. A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major. Eldor A; Maclouf J; Lellouche F; Ben-Yashar V; Barenholz Y; Durst R; Hy-Am E; Goldfarb A; Rachmilewitz E Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():92-5. PubMed ID: 7886616 [TBL] [Abstract][Full Text] [Related]
16. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related? Malyszko J; Malyszko J; Wolczynski S; Mysliwiec M Nephrol Dial Transplant; 2006 Jan; 21(1):145-52. PubMed ID: 16141459 [TBL] [Abstract][Full Text] [Related]
17. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis. Sirolli V; Strizzi L; Di Stante S; Robuffo I; Procopio A; Bonomini M Thromb Haemost; 2001 Sep; 86(3):834-9. PubMed ID: 11583316 [TBL] [Abstract][Full Text] [Related]
18. Does the choice of renal replacement therapy adversely affect the hypercoagulability associated with renal disease? Assouad M; Eknoyan G Am J Nephrol; 1998; 18(3):175-8. PubMed ID: 9627031 [TBL] [Abstract][Full Text] [Related]